Intelligence · Clinical Development
Pipeline search results
Programs matching “prostate-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 133 pipeline programs matching "prostate-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
177Lu-DOTA-TLX591
Telix Innovations
Prostate Cancer
1 trial -
177Lu-J591
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
177Lu-PSMA-617
United Therapeutics Europe Ltd
Metastatic Hormone Naive Prostate Cancer
1 trial -
2-deoxyglucose
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
225Ac-J591
United Therapeutics Europe Ltd
Prostate Cancer
2 trials -
225Ac-LNC1011
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
68Ga-G21
The First People's Hospital of Lianyungang
Prostate Cancer (Adenocarcinoma)
1 trial -
ADENOVIRUS/PSA VACCINE
United Therapeutics Europe Ltd
Hormone Refractory Prostate Cancer
1 trial -
AZD2265 (FPI-2265)
AstraZeneca
Metastatic Prostate Cancer
1 trial -
AZD5069
United Therapeutics Europe Ltd
Metastatic Castration Resistant Prostate Cancer
1 trial -
Abiraterone Acetate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
Abiraterone Acetate
United Therapeutics Europe Ltd
Metastatic Castration Resistant Prostate Cancer
1 trial -
Abiraterone acetate
United Therapeutics Europe Ltd
Prostate Cancer (Adenocarcinoma)
1 trial -
Aerobic exercise training
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Axumin PET/CT
HALOZYME THERAPEUTICS, INC.
Prostate Cancer
1 trial -
BXCL701 plus Pembrolizumab
BioXcel Therapeutics
Prostate Cancer
1 trial -
CEP-701
Teva Pharma GmbH
Prostate Cancer
1 trial -
Carboplatin
United Therapeutics Europe Ltd
Hormone Refractory Prostate Cancer
1 trial -
ChAdOx1-MVA 5T4 vaccine
Barinthus Biotherapeutics plc.
Intermediate Risk Prostate Cancer
1 trial -
ChAdOx1-PCAQ
Barinthus Biotherapeutics plc.
Prostate Cancer
1 trial -
Cyproterone acetate 5
Teva Pharma GmbH
Prostate Cancer
1 trial -
Darolutamide+ADT
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Degarelix
Regeneron UK Limited
Prostate Cancer
1 trial -
Docetaxel, Reolysin and Prednisone
ONCOLYTICS BIOTECH INC
Prostate Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.